Praxis Precision Medicines (PRAX) Other financing activities (2020 - 2023)

Praxis Precision Medicines' Other financing activities history runs 4 years deep, the most recent figure standing at $4.5 million for Q2 2023.

• In Q2 2023, Other financing activities changed N/A year-over-year to $4.5 million; the TTM figure through Dec 2023 stood at $4.5 million (up 1108.63% YoY), while the FY2022 annual figure was $262000.0, down 54.43% from the prior year.
• Other financing activities was $4.5 million for Q2 2023 at Praxis Precision Medicines, up from $109000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.5 million in Q2 2023 to a low of $4000.0 in Q2 2020.
• Historically, Other financing activities has averaged $1.0 million across 4 years, with a median of $262000.0 in 2022.
• Biggest YoY gain for Other financing activities was 5625.0% in 2021; the steepest drop was 79.12% in 2021.
• A 4-year view of Other financing activities shows it stood at $2.9 million in 2020, then tumbled by 79.12% to $598000.0 in 2021, then slumped by 81.77% to $109000.0 in 2022, then surged by 4013.76% to $4.5 million in 2023.
• The last three Other financing activities figures came in at $4.5 million (Q2 2023), $109000.0 (Q3 2022), and $262000.0 (Q1 2022), per Business Quant data.